Novo is ramping up manufacturing to satisfy soaring demand from customers in The us, where the drug sells for as much as $1,350 per month. It says it will eventually carefully keep an eye on prescriptions in Germany to ensure access for individuals with obesity, nonetheless it can't not rule out source delays.to scale back the potential risk of big